Prevention of cardiovascular diseases with anti-inflammatory and anti-oxidant nutraceuticals and herbal products: An overview of pre-clinical and clinical studies

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 12, Issue 2, 2018, Pages 145-157

  Jain, Sajal ^a   Buttar, Harpal S ^b   Chintameneni, Meena ^a   Kaur, Ginpreet ^a  

^a SVKM s Narsee Monjee Institute of Management Studies   (India)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Allium cepa; Allium sativum; Anti inflammation; Anti oxidant; Beta vulgaris; Cardiovascular diseases; Curcuma longa; Herbal product; Lagenaria siceraria; Murraya koenigii; Nutraceutical; Trigonella foenum graecum

Indexed keywords

CURCUMA LONGA EXTRACT; FENUGREEK EXTRACT; GARLIC EXTRACT; MURRAYA KOENIGII EXTRACT; NUTRACEUTICAL; ONION EXTRACT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BEET; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; HEALTH INSURANCE; HEART INFARCTION; HERBAL MEDICINE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LAGENARIA SICERARIA; LUNG EMBOLISM; NONHUMAN; OBESITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVIEW; RHEUMATIC HEART DISEASE; RISK FACTOR; SMOKING; ANIMAL; CLINICAL TRIAL (TOPIC); CURCUMA; DIETARY SUPPLEMENT; MURRAYA; PRECLINICAL STUDY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BETA VULGARIS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; CURCUMA; DIETARY SUPPLEMENTS; DRUG EVALUATION, PRECLINICAL; HERBAL MEDICINE; HUMANS; MURRAYA;

EID: 85053834205     PISSN: 1872213X     EISSN: 22122710     Source Type: Journal    
DOI: 10.2174/1872213X12666180815144803     Document Type: Review

References (84)

1. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemo-dialysis patients. Kidney Int 1999; 55(2): 648-58.
2. Mamtani R, Mamtani, R. Ayurveda and yoga in cardiovascular diseases. Card Rev 2005; 13(3): 155-62.
3. Barnes PJ, Peter J. Inflammatory mechanisms in chronic obstructive pulmonary disease. Sci & Med 2005; 9(5): 252-63.
4. Pirro M, Mannarino MR, Ministrini S, Fallarino F, Lupattelli G, Bianconi V, et al. Effects of a nutraceutical combination on lipids, inflammation and endothelial integrity in patients with subclinical inflammation: A randomized clinical trial. Sci Rep 2016; 23; 1-9. http://dx.doi.org/10.1038/srep23587 (Accessed on: July 4, 2018).
5. Gupta R, Joshi P, Mohan V, Reddy KS, Yusuf S. Epidemiology and causation of coronary heart disease and stroke in India. Heart 2008; 94(1): 16-26.
6. Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS, et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): A prospective analysis of registry data. The Lancet 2008; 371(9622): 1435-42.
7. Prince SA, Reid RD, Pipe AL, McDonnell LA. An evaluation of Cardio Prevent: A technology-enabled, health-behavior change program for the global reduction of cardiovascular risk. Cur Opinion in Card 2017; 32(5): 580-89.
8. Pandey M, Verma RK, Saraf SA. Nutraceuticals: New era of medicine and health. Asian J Pharm Clin Res 2010; 3(1): 11-5.
9. Rahal A, Kumar A. Cardiovascular diseases: Can herb-based anti-oxidant and anti-inflammatory functional products be a solution? React Oxy Spec 2016; 2(6): 404-16.
10. Shiao MS, Chiu JJ, Chang BW, Wang J, Jen WP, Wu YJ, et al. In search of antioxidants and anti-atherosclerotic agents from herbal medicines. Biofactors 2008; 34(2): 147-57.
11. Tsai HH, Lin HW, Simon Pickard A, Tsai HY, Mahady GB. Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: A systematic literature review. Int J Clin Pract 2012; 66(11): 1056-78.
12. Zaman TU, Adetunji HA, Salih EF. Nutraceuticals: A slow transition from preventive to curative healthcare and the pereceptions among physicians and patients: A study of south Delhi in India. Int J Pharm Sci Res 2017; 8(7): 3113-7.
13. Bagwe S, Tharappel LJ, Kaur G, Buttar HS. Bovine colostrum: An emerging nutraceutical. J Comp Integ Med 2015; 12(3): 175-85.
14. Walden R, Tomlinson B. 16 Cardiovascular disease. Lester Packer, Ph.D. 2011; 333-59.
15. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circ 2004; 109 (21 suppl 1): II-2-II-10.
16. Visen PK, Visen AS, Visen SS, Buttar HS, Singh RB. Management of Type 2 diabetes and atherosclerosis with alternative therapies. World Heart J 2015; 7(1): 63-82.
17. Johnston C. Functional foods as modifiers of cardiovascular disease. Americ J Lifestyle Med 2009; 3(1_suppl): 39S-43S.
18. Daftardar S, Kaur G, Addepalli V. Nutraceutical approaches in the management of cardiovascular dysfunctions associated with diabetes mellitus. In diabetic cardiomyopathy 2014; 377-96. Springer New York.
19. Zeng Y, Song JX, Shen XC. Herbal remedies supply a novel prospect for the treatment of atherosclerosis: A review of current mechanism studies. Phytotherapy Res 2012; 26(2): 159-67.
20. Rahal A, Mahima, Verma AK, Kumar A, Tiwari R, Kapoor S, Chakraborty S, Dhama K, et al. Phytonutrients and nutraceuticals in vegetables and their multi-dimensional medicinal and health benefits for humans and their companion animals: A review. J Bio Sci 2013; 1-19.
21. Kaur G, Buttar HS. Potential adverse interactions between allo-pathic drugs, herbals, and dietary products: Mechanisms of action and clinical implications. J Diab Metab Disord 2016; 3(009): 1-3.
22. Buttar HS, Li T, Ravi N. Prevention of cardiovascular diseases: Role of exercise, dietary interventions, obesity and smoking cessation. Exp Clin Cardio 2005; 10(4): 229-49.
23. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, et al. Markers of inflammation and cardiovascular disease. Circ 2003; 107(3): 499-511.
24. Hughes MF, Patterson CC, Appleton KM, Blankenberg S, Wood-side JV, Donnelly M, et al. The predictive value of depressive symptoms for all-cause mortality: Findings from the prime belfast study examining the role of inflammation and cardiovascular risk markers. Psychosom Med 2016; 78(4): 401-11.
25. Scrivo R, Vasile M, Bartosiewicz I, Valesini G. Inflammation as “common soil” of the multifactorial diseases. Autoimm Rev 2011; 10(7): 369-74.
26. Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimäki M, Batty GD. Association between psychological distress and mortality: Individual participant pooled analysis of 10 prospective cohort studies. BMJ 2012; 345: 1-14.
27. Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis. Circ J 2010; 74(2): 213-20.
28. Shrivastava AK, Singh HV, Raizada A, Singh SK. C-Reactive protein, inflammation, and coronary heart disease. The Egyp Heart J 2015; 67(2): 89-97.
29. Matloch Z, Cinkajzlova A, Mraze M, Haluzik M. The role of inflammation in epicardial adipose tissue in heart diseases. Cur Pharm Design 2018; 24(3): 297-309.
30. Baye E, de Courten MP, Walker K, Ranasinha S, Earnest A, Forbes JM, de Courten B, et al. Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: A randomised crossover trial. Sci Rep 2017; 7(1): 1-6.
31. Integrative Functional Medicine & Acupuncture Center. Available at: https://www.drionelahubbard.com/article/the-cardiovascular-inflammation-profile(Accessed on: July 4, 2018).
32. Nayadu S, Kaur G, Gudi G, Addepalli V. The potentials of selected therapeutic targets for inflammation: A snapshot. Recent Pat Inflamm Allergy Drug Discov 2012; 6(2): 137-46.
33. Furie B, Flaumenhaft R. Thiol isomerases in thrombus formation. Circ Res 2014; 114(7): 1162-73.
34. Wildman RE, Kelley M. Nutraceuticals and handbook of nutraceuticals and functional foods 2016; 2: 1-21.
35. Sirtori CR, Galli C, Anderson JW, Arnoldi A. Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: Focus on dietary proteins. Atheroscl 2009; 203(1): 8-17.
36. Kaur G, Mukundan S, Wani V, Kumar MS. Nutraceuticals in the management and prevention of metabolic syndrome. Austin J Pharm Ther. 2015; 3(1): 1-6.
37. Mannarino MR, Ministrini S, Pirro M. Nutraceuticals for the treatment of hypercholesterolemia. Eur J Int Med. 2014; 25(7): 592-9.
38. Zaki NM. Progress and problems in nutraceuticals delivery. J Bioeq & Bioavail 2014; 6(3): 075-7.
39. Alissa EM, Ferns GA. Functional foods and nutraceuticals in the primary prevention of cardiovascular diseases. J Nut Met 2012; 2012: 1-16.
40. Griffiths K, Aggarwal BB, Singh RB, Buttar HS, Wilson D, De Meester F, et al. Food antioxidants and their anti-inflammatory properties: a potential role in cardiovascular diseases and cancer prevention. Diseases 2016; 4(3): 28.
41. Thakur S, Srivastava N. Nutraceuticals: A Review. Asian J Res Pharm Sci 2016; 6(2): 85-94.
42. Patel D, Kaur G, Sawant MG, Deshmukh P. Herbal Medicine: A natural cure to arthritis. Indian J Nat Prod Res 2013; 4(1): 27-35.
43. Wilson DW, Nash P, Buttar HS, Griffiths K, Singh R, De Meester F, et al. The Role of food antioxidants, benefits of functional foods, and influence of feeding habits on the health of the older person: An overview. Antioxidants. 2017; 6(4): 81.
44. Tomé-Carneiro J, Visioli F. Polyphenol-based nutraceuticals for the prevention and treatment of cardiovascular disease: Review of the human evidence. Phytomed 2016; 23(11): 1145-74.
45. Johnston TP, Korolenko TA, Pirro M, Sahebkar A. Preventing cardiovascular heart disease: Promising nutraceutical and non-nutraceutical treatments for cholesterol management. Pharma Res 2017; 120: 219-25.
46. Omidvar S, Karn S, Shafiee S, Singh RB, Tokunaga M, Buttar HS, et al. Proatherogenic risk factors and under-nutrition among adolescents in South East Asia: When to eat and what to eat? World Heart J 2013; 5(4): 261-75.
47. Xie JT, Chang WT, Wang CZ, Mehendale SR, Li J, Ambihaipahar R, et al. Curry leaf (Murraya koenigii Spreng) reduces blood cholesterol and glucose levels in ob/ob mice. The Amer J Chin Med 2006; 34(02): 279-84.
48. Li Q, Zhu LF, But PP, Kong YC, Chang HT, Waterman PG, et al. Monoterpene and sesquiterpene rich oils from the leaves of Murraya species: Chemotaxonomic significance. Biochem System Eco 1988; 16(5): 491-94.
49. Nouman SM, Shehzad A, Butt MS, Khan MI, Tanveer M. Phyto-chemical profiling of curry (Murraya koenijii) leaves and its health benefits. Pak J Food Sci 2015; 25(4): 204-15.
50. Parachur, V.A., Ravicharan, S., Panda, S.K. A highly concentrated powder oleoresin composition and process for preparation thereof. WO2016185488 (2016).
51. Akhawri, S. A novel synergistic herbal formulation for degenerative disease cardiovascular diseases, autoimmune, inflammatory and metabolism disorder and the process of preparing the same. EP3240557 (2017).
52. Molly J, Edison S, Vijajaraghavan R, Ajith TA. Effect of curry leaves and cucumber fruit on lipid profile in menopausal women with hyperlipidemia: A randomized controlled pilot study. Int J Clin Trials 2017; 4(1): 7-13.
53. Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharm Sci 2009; 30(2): 85-94.
54. Fadus MC, Lau C, Bikhchandani J, Lynch HT. Curcumin: An age-old anti-inflammatory and anti-neoplastic agent. J Trad Compl Med 2016; 7(3): 339-46.
55. Wongcharoen W, Phrommintikul A. The protective role of curcumin in cardiovascular diseases. Int J Cardio 2009; 133(2): 145-51.
56. Jiang S, Han J, Li T, Xin Z, Ma Z, Di W, et al. Curcumin as a potential protective compound against cardiac diseases. Pharma Res 2017; 119: 373-83.
57. Deshpande, J., Juturu, V. Curcumin compositions for improvement in cardiovascular flow. WO2017081629 (2017).
58. Chakraborty M, Bhattacharjee A, Kamath JV. Cardioprotective effect of curcumin and piperine combination against cyclophos-phamide-induced cardiotoxicity. Indian J pharma 2017; 49(1): 65-70.
59. Ganjali S, Blesso CN, Banach M, Pirro M, Majeed M, Sahebkar A, et al. Effects of curcumin on HDL functionality. Pharma Res 2017; 119: 208-18.
60. Coles LT, Clifton PM. Effect of beetroot juice on lowering blood pressure in free-living, disease-free adults: A randomized, placebo-controlled trial. Nut J 2012; 11(1): 1-6.
61. Wruss J, Waldenberger G, Huemer S, Uygun P, Lanzerstorfer P, Müller U, et al. Compositional characteristics of commercial beetroot products and beetroot juice prepared from seven beetroot varieties grown in Upper Austria. J Food Comp Analy 2015; 42: 46-55.
62. Bryan NS. Dietary nitrite: From menace to marvel. Funct Foods Health Dis 2016; 6(11): 691-701.
63. Webb AJ, Patel N, Loukogeorgakis S, Okorie M, Aboud Z, Misra S, et al. Acute blood pressure lowering, vasoprotective, and anti-platelet properties of dietary nitrate via bioconversion to nitrite. Hyperten 2008; 51(3): 784-90.
64. El Gamal AA, AlSaid MS, Raish M, Al-Sohaibani M, Al-Massarani SM, Ahmad A, et al. Beetroot (Beta vulgaris L.) extract ameliorates gentamicin-induced nephrotoxicity associated oxidative stress, inflammation, and apoptosis in rodent model. Med Inflam 2014; 2014: 1-12.
65. Depta, B. Composition containing aronia berry extract, red spinach extract, and beetroot extract. US20170112886 (2017).
66. Siervo M, Lara J, Ogbonmwan I, Mathers JC. Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: A systematic review and meta-analysis. The J Nut 2013; 143(6): 818-26.
67. Banerjee SK, Maulik SK. Effect of garlic on cardiovascular disorders: A review. Nut J 2002; 1(1): 1-14.
68. Patel, A. Nutraceutical formulation for treatment of elevated cholesterol and cardiovascular disease. US20140314729 (2014).
69. Peng, L.V., Patricia, C.D.E., Beah, Z.M., Lau, K.G. Garlic compositions. WO2017119808 (2017).
70. Das L, Bhaumik E, Raychaudhuri U, Chakraborty R. Role of nutraceuticals in human health. J Food Sci Tech 2012; 49(2):173-183.
71. Upadhyay, 2016 Upadhyay RK. Nutraceutical, pharmaceutical and therapeutic uses of Allium cepa: A review. Int J Green Pharm 2016; 10(1): S46-64.
72. Sharma A, Kashyap D, Sak K, Tuli HS, Sharma AK. Therapeutic charm of quercetin and its derivatives: A review of research and patents. Pharma Patent Analyst 2018; 7(1): 15-32.
73. Lu TM, Chiu HF, Shen YC, Chung CC, Venkatakrishnan K, Wang CK, et al. Hypocholesterolemic efficacy of quercetin rich onion juice in healthy mild hypercholesterolemic adults: A pilot study. Plant Foods Hum Nut 2015; 70(4): 395-400.
74. Wani V, Dave A, Jadhav P, Kaur G. Effect of Lagenaria siceraria and Trigonella foenum graecum on lipid absorption and excretion for modulation of lipid profile. Sci Int 2015; 3(1): 18-24.
75. Mohale DS, Dewani AP, Saoji AN, Khadse CD. Antihyperlipidemic activity of isolated constituents from the fruits of Lagenaria siceraria in albino rats. Int J Green Pharm 2008;2(2): 104-07.
76. Mazed, M.A., Mazed, S. Nutritional supplement for the prevention of cardiovascular disease, Alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance. US8017147 (2011).
77. Ghule BV, Ghante MH, Saoji AN, Yeole PG. Antihyperlipidemic effect of the methanolic extract from Lagenaria siceraria stand fruit in hyperlipidemic rats. J Ethnopharma 2009; 124(2): 333-37.
78. El Bairi K, Ouzir M, Agnieszka N, Khalki L. Anticancer potential of Trigonella foenum graecum: Cellular and molecular targets. Biomed & Pharma 2017; 90: 479-91.
79. Belguith-Hadriche O, Bouaziz M, Jamoussi K, El Feki A, Sayadi S, Makni-Ayedi F, et al. Lipid-lowering and antioxidant effects of an ethyl acetate extract of fenugreek seeds in high-cholesterol-fed rats. J Agric and Food Chem 2010; 58(4): 2116-22.
80. Sajty M, Jackova L, Merkovska L, Jedlickova L, Fedacko J, Janicko M, et al. Fenugreek seeds decrease oxidative stress and blood lipids and increase nitric oxide in patients with hyperlipidemia. Atheroscl 2014; 235(2): e113.
81. Venkata KC, Bagchi D, Bishayee A. A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion. Mol Nut Food Res 2017; 61(6): 1-26.
82. Murthy, P.S., Moorthy, R., Prabhu, K.M., Puri, D. Anti-diabetic and cholesterol lowering preparation from fenugreek seeds. US7815946 (2010).
83. Mukthamba P, Srinivasan K. Protective effect of dietary fenugreek (Trigonella foenum-graecum) seeds and garlic (Allium sativum) alleviates oxidative stress in experimental myocardial infarction. Food Sci Human Wellness. 2017; 27(1): 1-9.
84. Yousefi E, Zareiy S, Zavoshy R, Noroozi M, Jahanihashemi H, Ardalani H, et al. Fenugreek: A therapeutic complement for patients with borderline hyperlipidemia: A randomised, double-blind, placebo-controlled, clinical trial. Adv Integ Med 2017; 4(1): 31-5.